Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis

Summary

The purpose of this randomised, double-blind, placebo-controlled, phase II study is to assess the efficacy and safety of orally administered DS102 in adult patients with acute decompensated alcoholic hepatitis

Timeline

Start

2018-11-28

Primary completion

2019-06-19

Completion

2020-03-31

Outcome

Outcome not reported

Stopped: “Company Decision”

Drugs

Indications